Mark Erlander - Chief Executive Officer, Director at Cardiff Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CRDF on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Erlander since 12/25/2023

Holdings reported by Mark Erlander for Cardiff Oncology, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options 2.17M $5.64M $2.60 Mar 7, 2024 Direct Common Stock

Transactions reported by Mark Erlander for Cardiff Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.